Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
Japan · Delayed Price · Currency is JPY 2,343.00
-3.00 (-0.13%)
Jan 21, 2026, 3:30 PM JST
TYO:4538 Revenue
Fuso Pharmaceutical Industries,Ltd. had revenue of 15.73B JPY in the quarter ending September 30, 2025, with 42.32% growth. This brings the company's revenue in the last twelve months to 62.05B, up 27.65% year-over-year. In the fiscal year ending March 31, 2025, Fuso Pharmaceutical Industries,Ltd. had annual revenue of 60.56B with 9.31% growth.
Revenue (ttm)
62.05B
Revenue Growth
+27.65%
P/S Ratio
0.32
Revenue / Employee
45.29M
Employees
1,370
Market Cap
20.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 60.56B | 5.16B | 9.31% |
| Mar 31, 2024 | 55.41B | 6.80B | 13.98% |
| Mar 31, 2013 | 48.61B | 4.25B | 9.59% |
| Mar 31, 2012 | 44.36B | -3.11B | -6.55% |
| Mar 31, 2011 | 47.47B | 909.00M | 1.95% |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |